In synopsis, we discovered that EWSR1-FLI1 hijacks SOX6 in EwS, which promotes tumor growth and modulates intracellular oxidative stress levels creating a therapeutic vulnerability toward oxidative stress-inducing drugs. The gene discussed is SOX6; the disease is neoplasm.